Caretaker Medical Adds ECG Patch to the Caretaker(R) Wireless Continuous Blood Pressure and Patient Monitoring Platform
CHARLOTTESVILLE, Va., Feb. 14, 2020 -- (Healthcare Sales & Marketing Network) -- Caretaker Medical, a leader in clinical-grade wireless patient monitoring and maker of the Caretaker® wearable patient monitor that utilizes a simple Finger Cuff to measu... Devices, Monitoring Caretaker Medical, Continuous Blood Pressure, wireless monitoring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 14, 2020 Category: Pharmaceuticals Source Type: news

Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
SAN DIEGO, Feb. 14, 2020 -- (Healthcare Sales & Marketing Network) -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patie... Diagnostics, Personnel Biocept, liquid biopsy, Target Selector, TRK proteins (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 14, 2020 Category: Pharmaceuticals Source Type: news

Kleo Pharmaceuticals Elects CEO Doug Manion, MD, FCRP (C), New Chairman of the Board
Former Board Chairman Dr. Tom Lynch, New President and Director at Fred Hutchinson Cancer Research Center, to Remain a Consultant NEW HAVEN, Conn., Feb. 14, 2020 -- (Healthcare Sales & Marketing Network) -- Kleo Pharmaceuticals, Inc., an immuno-oncolog... Biopharmaceuticals, Oncology, Personnel Kleo Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 14, 2020 Category: Pharmaceuticals Source Type: news

INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
SARASOTA, Fla., Feb. 13, 2020 -- (Healthcare Sales & Marketing Network) -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced the appointment of Inger B... Devices, Personnel INVO Bioscience, INVOcell, Assisted Reproductive Technology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 13, 2020 Category: Pharmaceuticals Source Type: news

Results Validating the Versatility of NuVasive's MaXcess(R) Retractor in Prone Single-Position XLIF(R) and Posterior Fixation Published in The European Spine Journal
SAN DIEGO, Feb. 13, 2020 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today annou... Devices, Orthopaedic, Neurosurgery NuVasive, pro-XLIF, MaXcess, retractor, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 13, 2020 Category: Pharmaceuticals Source Type: news

Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
SAN DIEGO, Feb. 13, 2020 -- (Healthcare Sales & Marketing Network) -- Decipher Biosciences, a commercial-stage precision oncology company committed to improving patient care, initially focused on urologic cancers, today announced that a Decipher GRID mole... Diagnostics, Oncology Decipher Biosciences, Decipher GRID, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 13, 2020 Category: Pharmaceuticals Source Type: news

Avidity Biosciences Appoints Joseph Baroldi as Chief Operating Officer
SAN DIEGO, Feb. 12, 2020 -- (Healthcare Sales & Marketing Network) -- Avidity Biosciences, Inc. (Avidity), a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), announced today the appointment of Joseph Baroldi as ... Biopharmaceuticals, Personnel Avidity Biosciences, Antibody-Oligonucleotide Conjugates, muscular dystrophy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 12, 2020 Category: Pharmaceuticals Source Type: news

BD, Babson Diagnostics Announce Strategic Partnership Agreement to Enable Small-Volume Blood Collection for Diagnostic Testing in Retail Settings
New capillary blood collection device combined with innovative sample handling and analytical technologies in clinical studies aim to make diagnostic blood testing more accessible and convenient FRANKLIN LAKES, N.J. and AUSTIN, Texas, Feb. 12, 2020 -- (... Devices, Diagnostics BD, Babson Diagnostics, blood collection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 12, 2020 Category: Pharmaceuticals Source Type: news

Regenexx, First to Use Stem Cells in Orthopedic Therapy, Marks 15th Anniversary
More than 90,000 procedures performed BROOMFIELD, Colo., Feb. 12, 2020 -- (Healthcare Sales & Marketing Network) -- Regenexx, the world's largest, cohesive physician group dedicated to practicing advanced orthobiologics and the first to use stem cells ... Regenerative Medicine, Orthopaedic Regenexx, orthobiologic, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 12, 2020 Category: Pharmaceuticals Source Type: news

Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
SAN DIEGO, Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally inaccessible targets, today announced the app... Biopharmaceuticals, Personnel Vividion Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

Soliton Files Special 510(k) with FDA for its Generation II RAP Device
Key step towards limited launch mid-2020 HOUSTON, Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform ... Devices, Dermatology, FDA Soliton, Rapid Acoustic Pulse, tattoo removal, Q-switched laser (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

Encoded Therapeutics Expands Gene Therapy Leadership with Key Appointment and Promotion
Salvador Rico, M.D., Ph.D., named Chief Medical Officer Martin Moorhead, Ph.D., promoted to Chief Technology Officer SOUTH SAN FRANCISCO, Calif., Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Encoded Therapeutics, Inc. (Encoded), a prec... Biopharmaceuticals, Personnel Encoded Therapeutics, gene therapy, Dravet Syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis
Primary Endpoint Achieved with High Statistical Significance LAVAL, QC, Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) – Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial derm... Biopharmaceuticals, Drug Delivery, Dermatology Crescita Therapeutics, MMPE, plaque psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

FDA Grants De Novo Clearance to Bluegrass Vascular Technologies for the Surfacer(R) Inside-Out(R) Access Catheter System
First device to reliably and repeatedly achieve central venous access from the inside-out in patients with venous obstructions SAN ANTONIO, Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Bluegrass Vascular Technologies (Bluegrass Vascular),... Devices, FDA Bluegrass Vascular Technologies, Surfacer System, Surfacer Inside-Out (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

Caris Life Sciences Appoints New Executive Medical Director
IRVING, Texas, Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today Matthew Oberley, M.D., Ph.D., has been ap... Diagnostics, Personnel Caris Life Sciences, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review
FDA Priority Review for capmatinib based on Phase II data in first-line and previously treated patients with MET exon 14 skipping (METex14) mutated advanced non-small cell lung cancer (NSCLC)(1) Substantial unmet need exists among patients with METex14 ... Biopharmaceuticals, Oncology Novartis, capmatinib, METex14, NSCLC, lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Accomplished Biopharmaceutical and Drug Development Executive to Lead the Expansion of Enteris' External and Internal Development Programs BOONTON, N.J., Feb. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Enteris BioPharma, Inc., a biotechnolog... Biopharmaceuticals, Drug Delivery, Personnel Enteris BioPharma, Peptelligence, Ovarest, leuprolide, endometriosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 10, 2020 Category: Pharmaceuticals Source Type: news

Tenon Medical, Inc. Releases the Results of the First Post-Clearance Clinical Study
SAN RAMON, Calif., Feb. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Tenon Medical, Inc., a manufacturer of instruments and implants for sacroiliac joint fusion surgery, today announced the completion of the first phase of its post-approval clini... Devices, Orthopaedic Tenon Medical, Catamaran, Sacroiliac Joint Fixation, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 10, 2020 Category: Pharmaceuticals Source Type: news

Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
NEW HAVEN, Conn., Feb. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today reported negative topline results from its Phase 3 clinical trial evaluating troriluzole compared to placebo for t... Biopharmaceuticals Biohaven Pharmaceutical, troriluzole, Generalized Anxiety Disorder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 10, 2020 Category: Pharmaceuticals Source Type: news

CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
REHOVOT, Israel, Feb. 10, 2020 -- (Healthcare Sales & Marketing Network) -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the appointment of Roger J. Pomerantz, M.D., F.A.C.P. to its Board of Directors as Chairma... Regenerative Medicine, Personnel CollPlant, 3D bioprinting, recombinant human collagen, collagen (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 10, 2020 Category: Pharmaceuticals Source Type: news

Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Study with novel trial design did not meet primary endpoint INDIANAPOLIS, Feb. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced that the analysis performed by Washington University School of Medici... Biopharmaceuticals, Neurology Eli Lilly, solanezumab, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 10, 2020 Category: Pharmaceuticals Source Type: news

Perrigo Announces Consumer Self-Care Americas Segment Leadership Transition
DUBLIN, Feb. 7, 2020 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of Quality, Affordable Self-Care Products™, today announced the future retirement of Jeff Needham, Executive Vice President... Biopharmaceuticals, Personnel Perrigo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2020 Category: Pharmaceuticals Source Type: news

Pharvaris Appoints Peng Lu, M.D., Ph.D., as Chief Medical Officer
Company strengthens executive team with addition of skilled HAE drug developer LEIDEN, Netherlands, Feb. 7, 2020 -- (Healthcare Sales & Marketing Network) -- Pharvaris B.V., a clinical-stage company focused on the discovery and development of novel ora... Biopharmaceuticals, Personnel Pharvaris, hereditary angioedema, angioedema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2020 Category: Pharmaceuticals Source Type: news

Elios Therapeutics Presents New Phase IIb Data for Personalized Cancer Vaccine in High-Risk Melanoma Patients at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Vaccine Was Most Effective in Stage IV Melanoma; 73 Percent of Patients Who Completed the Primary Vaccine Series Were Disease-Free at 24 Months Results Reflect Synergistic Anti-Tumor Effect When Vaccine is Combined with Checkpoint Inhibitors AUSTIN, ... Biopharmaceuticals, Oncology Elios Therapeutics, cancer vaccine, melanoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2020 Category: Pharmaceuticals Source Type: news

Sonendo(R) Appoints Andrew Kirkpatrick as Chief Operating Officer
LAGUNA HILLS, Calif., Feb. 6, 2020 -- (Healthcare Sales & Marketing Network) -- Sonendo®, Inc., a dental technology company developing and commercializing products to save teeth through Sound Science®, announced today the appointment of Andrew Kir... Devices, Dental, Personnel Sonendo, GentleWave, endodontic therapy, root canal therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2020 Category: Pharmaceuticals Source Type: news

SMART Medical Systems Launches G-EYE(R) 760R Colonoscope in the European Endoscopy Market Through FUJIFILM Europe, Under Strategic Distribution Partnership with FUJIFILM Corporation, to Provide Synergetic Colonoscopy Solution in Fight Against Colon Cancer
SMART's G-EYE® 760R colonoscope, incorporating its G-EYE® Balloon Technology designed to increase the detection of cancerous polyps in colonoscopy, will become available by FUJIFILM Europe with its state-of-the-art ELUXEO system, as part of the new... Devices, Oncology, Product Launch, Distribution SMART Medical Systems, Fujifilm, G-EYE, colonoscope, colonoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2020 Category: Pharmaceuticals Source Type: news

Imagion Biosystems Appoints Vice President Clinical and Regulatory Affairs
SAN DIEGO, Feb. 5, 2020 -- (Healthcare Sales & Marketing Network) -- Imagion Biosystems, a company dedicated to improving healthcare through the earlier detection of cancer, announces the appointment of Dr. Oliver Steinbach as Vice President of Clinical a... Diagnostics, Oncology, Personnel Imagion Biosystems, nanoparticles (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2020 Category: Pharmaceuticals Source Type: news

Ichnos Expands Leadership Team With Appointment Of Gabriela Gruia, M.D. As Chief Development Officer
PARAMUS, N.J., Feb. 5, 2020 -- (Healthcare Sales & Marketing Network) -- Ichnos Sciences Inc. is pleased to announce that Gabriela Gruia, M.D. has assumed the role of Chief Development Officer, effective immediately. In this position, Gabriela will overse... Biopharmaceuticals, Personnel Ichnos Sciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2020 Category: Pharmaceuticals Source Type: news

Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
SOUTH SAN FRANCISCO, Calif., Feb. 5, 2020 -- (Healthcare Sales & Marketing Network) -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering a... Biopharmaceuticals, Oncology, Personnel Sutro Biopharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2020 Category: Pharmaceuticals Source Type: news

Studies Support Use of the Accuray TomoTherapy(R) System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects
SUNNYVALE, Calif., Feb. 5, 2020 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy® System in the treatment of advanced rectal cancer. Radio... Devices, Oncology Accuray, radiotherapy, TomoTherapy, Radixact, rectal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2020 Category: Pharmaceuticals Source Type: news

Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
ABBOTT PARK, Ill., Feb. 4, 2020 -- (Healthcare Sales & Marketing Network) -- Abbott (NYSE: ABT) today announced that the company has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Imp... Devices, Cardiology, FDA Abbott, Left Ventricular Assist, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 4, 2020 Category: Pharmaceuticals Source Type: news

Serenno Medical Introduces Novel Device for Continuous Automatic Monitoring of Kidney Function of Hospitalized Patients
Sentinel™ bedside urine output monitor for early detection and prevention of Acute Kidney Injury reduces patient risk YOKNEAM, Israel, Feb. 4, 2020 -- (Healthcare Sales & Marketing Network) -- Serenno Medical, developer of medical devices for patient m... Devices, Monitoring, Product Launch Serenno Medical, Sentinel, urine output monitor, Acute Kidney Injury (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 4, 2020 Category: Pharmaceuticals Source Type: news

Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer
Brings to Portola 20 Years of Clinical Development and Approval Experience SOUTH SAN FRANCISCO, Calif., Feb. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced the appointment of Rajiv... Biopharmaceuticals, Personnel Portola Pharmaceuticals, Andexxa, coagulation factor Xa, Bevyxxa, betrixaban (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 3, 2020 Category: Pharmaceuticals Source Type: news

7D Surgical Expands Spine and Cranial Technology Offering
TORONTO, Feb. 3, 2020 -- (Healthcare Sales & Marketing Network) -- 7D Surgical announced today important additions to its cranial and spinal product lines. The company has received both 510(k) clearance from the U.S. Food and Drug Administration (FDA) an... Devices, Neurosurgery, FDA, Product Launch 7D Surgical, Cranial Biopsy, MvIGS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 3, 2020 Category: Pharmaceuticals Source Type: news

A Revolution in Laparoscopic Training: KARL STORZ and VirtaMed Leap Beyond VR Simulation
TUTTLINGEN, Germany and ZURICH, Feb. 3, 2020 -- (Healthcare Sales & Marketing Network) -- KARL STORZ, the leading endoscopy manufacturer, and VirtaMed, world leader in medical training simulation, introduce a novel mixed reality simulator bringing innovat... Devices, Product Launch KARL STORZ, VirtaMed, endoscopy, medical training simulation, LapTrainer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 3, 2020 Category: Pharmaceuticals Source Type: news

Eisai Inc. Expands Leadership Team in the US with the Appointment of Two Key Leaders
Executive Appointments: Joel W. Beetsch, Vice President, Corporate Affairs, Eisai Inc. Scott R. Steuart, Vice President, Market Access, Eisai Inc. WOODCLIFF LAKE, N.J., Feb. 3, 2020 -- (Healthcare Sales & Marketing Network) -- As Eisai Inc. conti... Biopharmaceuticals, Personnel Eisai, dementia, neurodegenerative (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 3, 2020 Category: Pharmaceuticals Source Type: news

Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering
Former Senior Director at Illumina, Inc. was Instrumental in Developing the World-Class Sequencing System that Enabled the $1000 Genome SAN DIEGO, Feb. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Truvian Sciences ("Truvian"), a healt... Diagnostics, Personnel Truvian Sciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 3, 2020 Category: Pharmaceuticals Source Type: news

Hillrom Improves Hypertension Detection With New Welch Allyn(R) Spot Vital Signs(R) 4400 Device
Latest vital signs device provides caregivers with an advanced, more efficient patient vitals solution CHICAGO, Feb. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Global medical technology leader Hillrom today announced the commercial launch of ... Devices, Product Launch Hillrom, Welch Allyn, Spot Vital Signs 4400 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 3, 2020 Category: Pharmaceuticals Source Type: news

Olympus Announces FDA Clearance of the TJF-Q190V Duodenoscope
Duodenoscope with Sterile, Disposable Endcap Improves Ease of Reprocessing while Offering Advanced Features for Improved Clinical Performance CENTER VALLEY, Pa., Jan. 31, 2020 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology le... Devices, Gastroenterology, FDA Olympus Medical Systems, Duodenoscope, TJF-Q190V (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2020 Category: Pharmaceuticals Source Type: news

AbbVie Receives Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis
If approved by the European Commission (EC), MAVIRET will be the only pan-genotypic (GT1-6) 8-week treatment option for treatment-naïve, chronic hepatitis C (HCV) patients, without cirrhosis or with compensated cirrhosis Final European Commission ... Biopharmaceuticals, Regulatory AbbVie, MAVIRET, glecaprevir, pibrentasvir, hepatitis C (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2020 Category: Pharmaceuticals Source Type: news

AbbVie Receives Positive CHMP Opinion for VENCLYXTO(R) as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia
If approved by the European Commission (EC), VENCLYXTO® plus obinutuzumab would be the first chemotherapy-free, combination regimen given with a fixed duration for patients with previously untreated chronic lymphocytic leukemia (CLL) Represents thir... Biopharmaceuticals, Oncology, Regulatory AbbVie, VENCLYXTO, venetoclax, chronic lymphocytic leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2020 Category: Pharmaceuticals Source Type: news

Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option Tendyne valve provides relief from heart failure symptoms and quality-of-life improvement in high-surgical-risk patient... Devices, Interventional, Cardiology, Regulatory Abbott, Tendyne, Transcatheter, Mitral Valve, TMVI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2020 Category: Pharmaceuticals Source Type: news

SutroVax Announces Executive Appointment
Jim Wassil appointed Chief Operating Officer FOSTER CITY, Calif., Jan. 30, 2020 -- (Healthcare Sales & Marketing Network) -- SutroVax, a biopharmaceutical company dedicated to developing best-in-class conjugate vaccines and novel complex antigen-based ... Biopharmaceuticals, Personnel SutroVax (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2020 Category: Pharmaceuticals Source Type: news

Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership
Allergan Granted Exclusive Rights to Market Histogen's CCM in Dermabrasion Therapies SAN DIEGO, Jan. 30, 2020 -- (Healthcare Sales & Marketing Network) -- Histogen Inc., a regenerative medicine company with a unique biological platform that replaces an... Biopharmaceuticals, Regenerative Medicine, Licensing Histogen, Allergan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2020 Category: Pharmaceuticals Source Type: news

Insmed Appoints Sara Bonstein as Chief Financial Officer
BRIDGEWATER, N.J., Jan. 30, 2020 -- (Healthcare Sales & Marketing Network) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the appoint... Biopharmaceuticals, Personnel Insmed (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2020 Category: Pharmaceuticals Source Type: news

Oramed Appoints Dr. Julio Rosenstock to Its Scientific Advisory Board
NEW YORK, Jan. 30, 2020 -- (Healthcare Sales & Marketing Network) -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announce... Biopharmaceuticals, Drug Delivery, Personnel Oramed Pharmaceuticals, Protein Oral Delivery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2020 Category: Pharmaceuticals Source Type: news

Monoferric(R) (Ferric Derisomaltose) Injection Is Approved by the US FDA for the Treatment of Iron Deficiency Anemia
MORRISTOWN, N.J., Jan. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Pharmacosmos Therapeutics Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Monoferric® (ferric derisomaltose) injection 100 mg/mL. M... Biopharmaceuticals, FDA Pharmacosmos Therapeutics, Monoferric, ferric derisomaltose, anemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2020 Category: Pharmaceuticals Source Type: news

CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
CytoSorb is the only approved therapy to remove ticagrelor in the European Union, and is intended to address a major unmet medical need of potentially life-threatening postoperative bleeding in cardiothoracic surgery patients on the drug MONMOUTH JUNCTI... Devices, Regulatory, Product Launch CytoSorbents, CytoSorb, blood purification (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2020 Category: Pharmaceuticals Source Type: news

Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application
INDIANAPOLIS, Jan. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) for selpercatinib (L... Biopharmaceuticals, Oncology, FDA Eli Lilly, selpercatinib, RET-mutant, thyroid cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2020 Category: Pharmaceuticals Source Type: news

vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)
Top-line results expected end of 2020 WÜRZBURG, Germany, Jan. 29, 2020 -- (Healthcare Sales & Marketing Network) -- vasopharm GmbH, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular dise... Biopharmaceuticals, Neurology vasopharm, ronopternin, traumatic brain injury (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2020 Category: Pharmaceuticals Source Type: news